US Coronary Artery Bypass Graft Market Research Report: By Type (Off-Pump, On-Pump, Minimally Invasive Direct CABG, Endoscopic Vein Harvesting, Others), By Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery, Others) and By End-Users (Hospitals, Cardiology Clinics, Research Institutes, Others) - Forecast to 2035

US Coronary Artery Bypass Graft Market Research Report: By Type (Off-Pump, On-Pump, Minimally Invasive Direct CABG, Endoscopic Vein Harvesting, Others), By Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery, Others) and By End-Users (Hospitals, Cardiology Clinics, Research Institutes, Others) - Forecast to 2035.

US Coronary Artery Bypass Graft Market Overview:

As per MRFR analysis, the US Coronary Artery Bypass Graft Market Size was estimated at 2.58 (USD Billion) in 2023. The US Coronary Artery Bypass Graft Market Industry is expected to grow from 2.9(USD Billion) in 2024 to 7 (USD Billion) by 2035. The US Coronary Artery Bypass Graft Market CAGR (growth rate) is expected to be around 8.341% during the forecast period (2025 - 2035).

Key US Coronary Artery Bypass Graft Market Trends Highlighted

The US Coronary Artery Bypass Graft market is experiencing several important trends driven by advancements in medical technology and shifts in healthcare policies. One key market driver is the increasing prevalence of coronary artery disease (CAD) among the US population, closely linked to lifestyle factors such as obesity and diabetes. The aging population further contributes to this trend, as older adults are more susceptible to heart-related issues. Additionally, there is a growing emphasis on minimally invasive surgical techniques. Techniques such as off-pump CABG and the use of robotic assistance are gaining traction, as they generally result in faster recovery times and fewer complications for patients.Opportunities in this market can be explored through the development of innovative graft materials and the enhancement of postoperative care tools. Focused research on bioengineered grafts, which may improve outcomes, is gaining attention. Furthermore, the integration of telehealth into preoperative and postoperative management is creating avenues for better patient monitoring and reduced hospital readmissions. Recent trends also show an increasing interest in personalized medicine, allowing for tailored surgical approaches based on genetic or lifestyle factors, which enhances the effectiveness of treatments. In terms of market dynamics, a shift toward value-based healthcare is influencing how surgical procedures are performed, driving hospitals and surgical centers to adopt protocols that focus on patient outcomes rather than volume of procedures.Emergency medical systems in the US are also prioritizing rapid transport and treatment protocols for cardiac events, ensuring that timely care is available to those in need. This rapid evolution in cardiac care reflects a comprehensive approach to managing heart health in the US, showcasing a commitment to improving patient outcomes and adapting to emerging trends.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Coronary Artery Bypass Graft Market Drivers

Increasing Incidence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases is one of the most significant drivers in the US Coronary Artery Bypass Graft Market Industry. According to the Centers for Disease Control and Prevention, approximately 697,000 Americans died from heart disease in 2020, making it the leading cause of death in the United States. This staggering statistic indicates a growing patient population needing interventions like coronary artery bypass grafting, driving demand for surgical procedures.Additionally, the American Heart Association emphasizes that between 2020 and 2021, there was an increase in the prevalence of coronary artery disease among adults aged 45 and above, with a reported prevalence rate of approximately 7.2% to 8.5%. These trends highlight the increasing need for effective treatment options, thus propelling the growth of the US Coronary Artery Bypass Graft Market.

Technological Advancements in Surgical Procedures

Ongoing technological advancements in surgical procedures significantly contribute to the US Coronary Artery Bypass Graft Market Industry's growth. Innovations in minimally invasive surgical techniques have improved patient outcomes and reduced recovery times. For example, the introduction of robotic-assisted surgeries has increased the precision of procedures. The Food and Drug Administration has reported an increase in the approval of new surgical devices and procedures, demonstrating a commitment to advancing cardiovascular care.As facilities adopt these cutting-edge technologies, they enhance their service offerings, meeting rising patient expectations, thereby driving the demand for coronary artery bypass grafts in the US.

Aging Population

The aging population in the United States is a vital driver for the US Coronary Artery Bypass Graft Market. According to the United States Census Bureau, the number of Americans aged 65 and older is projected to reach approximately 94.7 million by 2060, nearly double the current figures. This demographic shift signifies an increased prevalence of age-related health conditions, particularly cardiovascular diseases. Older adults are at higher risk for conditions demanding surgical interventions like coronary artery bypass grafts.Hence, this growing segment of the population will likely propel higher demand for such procedures, significantly benefiting the US Coronary Artery Bypass Graft Market.

Rising Healthcare Expenditure

Rising healthcare expenditure in the United States bolsters the US Coronary Artery Bypass Graft Market. The Centers for Medicare & Medicaid Services indicate that national health expenditures are projected to reach $6.2 trillion by 2028, reflecting a steady increase in spending. This surge in healthcare spending translates to enhanced funding for medical procedures, including coronary artery bypass grafts, as patients gain better access to advanced treatment options.Furthermore, with more insurers providing coverage for surgical treatments, the financial barriers are diminished, leading to an increase in procedures performed and a consequent growth in the market.

US Coronary Artery Bypass Graft Market Segment Insights:

Coronary Artery Bypass Graft Market Type Insights

The US Coronary Artery Bypass Graft Market encompasses various types of procedures that are essential for treating coronary artery disease, and each type plays a significant role within this market. Off-Pump Coronary Artery Bypass Graft, or OPCAB, is gaining recognition as it allows surgeries to be performed without having to stop the heart, which can lead to less postoperative complications and quicker recovery times. This method offers advantages such as reduced need for blood transfusions and shorter hospital stays, making it an appealing option for both patients and healthcare providers in the US. On the other hand, traditional On-Pump techniques involve using a heart-lung machine during the surgery. Despite the advancements in minimally invasive techniques, On-Pump remains relevant due to its reliability and effectiveness in complex cases, appealing to a segment of patients requiring extensive intervention. Minimally Invasive Direct Coronary Artery Bypass Graft (MIDCAB) is also carving its niche by emphasizing smaller incisions and less trauma to the chest, which can greatly enhance recovery times and decrease pain levels. This collected approach not only aligns with broader healthcare trends favoring less invasive interventions but also resonates with patients seeking options that promise quicker return to normal activities. Endoscopic Vein Harvesting is another crucial technique, crucial for obtaining vein grafts through minimal incisions. This has become increasingly standard as it promotes faster healing and diminishes post-operative complications related to larger surgical sites. Other emerging techniques and innovations within the US market are constantly evaluated for their benefits in the treatment of coronary artery disease, presenting opportunities for healthcare facilities to adopt advanced surgical methodologies. Each of these types within the US Coronary Artery Bypass Graft Market influences the overall landscape significantly and can redefine patient care standards moving forward. As the market continues to evolve, the integration of these techniques reflects ongoing trends in cardiovascular care, affordability, and patient-centric approaches. Overall, understanding the dynamics of these types will be vital for stakeholders navigating the complexities of the US Coronary Artery Bypass Graft Market industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Coronary Artery Bypass Graft Market Procedure Insights

The Procedure segment of the US Coronary Artery Bypass Graft Market plays a crucial role in addressing the increasing prevalence of coronary artery disease across the region. The segment includes several types of surgeries, such as Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery, and others, each catering to varying patient needs and complexities of heart conditions. Single CABG Surgery is often the most common choice, providing a simpler option for patients with less severe artery blockages, while Double and Triple CABG Surgeries account for more complex cases, offering improved blood flow and quality of life for patients with multiple blockages.Quadruple CABG Surgery, though less frequent, indicates a critical need for intervention in patients with extensive coronary artery disease and demonstrates the evolving capabilities of cardiac surgeons. Overall, the Procedure segment underscores significant advancements in surgical techniques and technologies, contributing to enhanced outcomes and patient care in the US, driven by growing demographic demands and increased awareness of heart diseases. The market is navigating through trends such as minimally invasive techniques and patient-specific solutions, which elevate the importance of understanding each surgical type's role in comprehensive cardiovascular treatment.

Coronary Artery Bypass Graft Market End-Users Insights

The End-Users segment of the US Coronary Artery Bypass Graft Market is critical, encompassing various healthcare settings that provide cardiac care. Hospitals play a dominant role as they handle the majority of bypass surgeries, offering comprehensive facilities and specialized staff necessary for procedural complexities. Cardiology Clinics are significant as they allow for focused treatment options and follow-up care, enhancing patient satisfaction and outcomes. Research Institutes contribute immensely to the development of innovative techniques and technologies, driving advancements in coronary bypass procedures.Additionally, other healthcare facilities serve niche markets, catering to specific patient needs and preferences. The US is experiencing a rise in cardiovascular diseases, impacting the demand across these end-user categories. Moreover, the integration of minimally invasive techniques and collaborative approaches among these facilities is transforming the patient care landscape, creating ample growth opportunities. As healthcare policymakers emphasize cardiovascular health, this segment's role will likely expand, further shaping the US Coronary Artery Bypass Graft Market dynamics.

US Coronary Artery Bypass Graft Market Key Players and Competitive Insights:

The US Coronary Artery Bypass Graft Market is a dynamic arena characterized by a mixture of established players and emerging companies, all vying for a share in a space driven by innovation and the increasing demand for cardiovascular interventions. As cardiovascular diseases continue to rise in prevalence, the need for effective surgical solutions, such as coronary artery bypass grafting (CABG), has led to heightened competition among market participants. Companies are focused on developing advanced technologies and improving patient outcomes through various grafting techniques and support devices. The competitive landscape is shaped by factors such as research and development, regulatory compliance, product differentiation, and strategic partnerships, all aimed at enhancing market penetration and addressing the specific needs of healthcare providers and patients in the US.Teleflex has solidified its presence in the US Coronary Artery Bypass Graft Market by leveraging its strong portfolio of innovative medical devices aimed at improving surgical efficiency and patient care. The company is known for its commitment to quality and excellence in engineering, ensuring that their products meet the rigorous standards required in highly specialized medical procedures. Teleflex's strengths lie in its well-established relationships with healthcare professionals, robust customer support, and continuous investment in research to develop cutting-edge products that align with the latest advancements in the field. By focusing on enhancing procedural safety and efficacy, Teleflex has positioned itself as a preferred choice among healthcare providers, contributing to its sustained growth within the US market.C.R. Bard has also carved a significant niche in the US Coronary Artery Bypass Graft Market, driven by its commitment to providing high-quality vascular solutions. The company offers a range of products tailored for CABG procedures, including vascular grafts and interventional devices that enhance surgical outcomes. C.R. Bard's strengths stem from its extensive research background, enabling the introduction of innovative products that meet evolving clinical demands. The company's market presence has been bolstered by strategic mergers and acquisitions, which have expanded its product offerings and technological capabilities within the cardiovascular domain. With a focus on quality and performance, C.R. Bard continuously develops its portfolio to ensure that it meets the needs of both patients and healthcare providers, further solidifying its reputation in the competitive landscape of the US CABG market.

Key Companies in the US Coronary Artery Bypass Graft Market Include:

Teleflex

C.R. Bard

Terumo Corporation

Medtronic

Boston Scientific

Abbott Laboratories

Edwards Lifesciences

ARTELES

Cardinal Health

B. Braun Melsungen

Stryker Corporation

Cook Medical

AngioDynamics

Johnson and Johnson

CardioMed Technologies

US Coronary Artery Bypass Graft Market Industry Developments

The US Coronary Artery Bypass Graft Market has seen several notable developments recently, including growth trends in valuations of key companies such as Medtronic, Abbott Laboratories, and Edwards Lifesciences. In December 2022, Medtronic announced plans to acquire Mazor Robotics, enhancing their capabilities in minimally invasive coronary procedures. Additionally, in August 2023, Teleflex expanded its cardiac portfolio through its acquisition of ADC Therapeutics, which focuses on innovative medical devices for cardiac patients. Current affairs in the market are heavily influenced by regulatory changes aimed at ensuring patient safety and improving surgical outcomes. The demand for advanced bypass graft techniques is on the rise, fueled by an increase in coronary artery disease cases in the US, where it remains one of the leading causes of morbidity and mortality. The market is also witnessing significant technological advancements in graft materials and surgical techniques. Over the past few years, key events, such as a surge in funding for Research and Development initiatives in cardiovascular treatments, have significantly impacted the market dynamics by encouraging innovation and driving competition among established companies like Boston Scientific and Johnson and Johnson.

US Coronary Artery Bypass Graft Market Segmentation Insights

Coronary Artery Bypass Graft Market Type Outlook

Off-Pump

On-Pump

Minimally Invasive Direct CABG

Endoscopic Vein Harvesting

Others

Coronary Artery Bypass Graft Market Procedure Outlook

Single CABG Surgery

Double CABG Surgery

Triple CABG Surgery

Quadruple CABG Surgery

Others

Coronary Artery Bypass Graft Market End-Users Outlook

Hospitals

Cardiology Clinics

Research Institutes

Others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	2.58(USD Billion)
MARKET SIZE 2024	2.9(USD Billion)
MARKET SIZE 2035	7.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.341% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Teleflex, C.R. Bard, Terumo Corporation, Medtronic, Boston Scientific, Abbott Laboratories, Edwards Lifesciences, ARTELES, Cardinal Health, B. Braun Melsungen, Stryker Corporation, Cook Medical, AngioDynamics, Johnson and Johnson, CardioMed Technologies
SEGMENTS COVERED	Type, Procedure, End-Users
KEY MARKET OPPORTUNITIES	Minimally invasive surgical techniques, Increasing geriatric population, Advanced biomaterials development, Rising prevalence of cardiovascular diseases, Growth in health insurance coverage
KEY MARKET DYNAMICS	Aging population, Increasing heart diseases, Technological advancements, Rising healthcare expenditure, Growing awareness and prevention
COUNTRIES COVERED	US